✦ LIBER ✦

Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: Results of a Spanish multicenter study

✍ Scribed by Javier de la Rubia; Federico Moscardó; María J Gómez; Ramón Guardia; Pilar Rodríguez; Ana Sebrango; Concepción Zamora; Guillermo Debén; Rosa Goterris; Rafaela López; Francisco Peña; Misericordia Pujol; Antonio Vidaller; Julio del Río-Garma; Miguel A. Sanz

Book ID: 116928970
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 181 KB
Volume: 43
Category: Article
ISSN: 1473-0502
DOI: 10.1016/j.transci.2010.09.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of rituximab in acute refractor

Efficacy of rituximab in acute refractory or chronic relapsing non-familial idiopathic thrombotic thrombocytopenic purpura: a systematic review with pooled data analysis

✍ Nay M. Tun, Gina M. Villani 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 253 KB

Clinical efficacy and safety of Flebogam

Clinical efficacy and safety of Flebogammadif®, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura

✍ A. Julia; L. Kovaleva; S. Loria; I. Alberca; F. Hernandez; V. Sandoval; J. Sierr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 518 KB

5.23 Phase 2 Study of Navitoclax (ABT-26

5.23 Phase 2 Study of Navitoclax (ABT-263) Safety and Efficacy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Interim Results

✍ John F. Seymour; Andrew W. Roberts; Dennis A. Carney; Martin J.S. Dyer; Thomas J 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 71 KB

Safety and efficacy of bortezomib and me

Safety and efficacy of bortezomib and melphalan combination in patients with relapsed or refractory multiple myeloma: updated results of a phase 1/2 study after longer follow-up

✍ James R. Berenson; Hank H. Yang; Robert A. Vescio; Youram Nassir; Russell Mapes; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 164 KB

Bendamustine Combined With Rituximab in

Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

✍ Fischer, K.; Cramer, P.; Busch, R.; Stilgenbauer, S.; Bahlo, J.; Schweighofer, C 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 141 KB

Efficacy and safety of nilotinib in Japa

Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL: a 36-month analysis of a phase I and II study

✍ Kensuke Usuki; Arinobu Tojo; Yasuhiro Maeda; Yukio Kobayashi; Akira Matsuda; Kaz 📂 Article 📅 2012 🏛 Carden Jennings Publishing 🌐 English ⚖ 285 KB